Ionis Pharmaceuticals Inc. (NASDAQ:IONS) Provides Updates Of Its 2020 Achievements And...

0
Ionis Pharmaceuticals Inc. (NASDAQ:IONS) has highlighted is achievements in 2020 and offered a strategy that will help its realize considerable opportunity for...

Heron Therapeutics Inc. (NASDAQ:HRTX) Resubmits HTC-011 New Drug Application To The...

0
Heron Therapeutics Inc. (NASDAQ:HRTX) has announced the resubmission of the New Drug Application for HTX-011 to the US FDA. HTX-011 is an...

Popular News

Cure SMA and Cytokinetics, Inc. (NASDAQ:CYTK) Expands It Partnership to Intensify...

0
Cytokinetics, Inc. (NASDAQ:CYTK) has built a 20-year history of successful business operations through advanced research and innovation. The company has grown into being a...

MAKE IT MODERN

LATEST REVIEWS

Onconova Therapeutics Inc (NASDAQ:ONTX) Expects To Announce Topline Data Of Inspire...

0
Onconova Therapeutics Inc (NASDAQ:ONTX) anticipates reporting topline data by the end of Q3 2020 following it’s INSPIRE clinical study achieving all the survival points. IND...

MAKE IT MODERN

PERFORMANCE TRAINING

Incyte Corporation

Incyte (NASDAQ:INCY) Enters Agreement With Nimble Therapeutics For the discovery of Peptide Therapies

0
Incyte (NASDAQ:INCY) has entered a strategic collaboration with Nimble Therapeutics Inc. for the discovery of first in class peptide therapies in different disease areas. Nimble...

SPY breaks through resistance at 331.66 to head higher

0
The market made a big move higher overnight, again and is currently sitting at 331.84 haveing just broken through resistance at 331.66....

Stocks to End the Opioid Epidemic (ECOR, PCRX, ENDV, NVCR)

0
Opioid drugs have done more damage over the last few years than Covid-19. But now, because of the pandemic, the opioid crisis has significantly...

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Enrols First Subject In COV-Logic Study Evaluating TNX-1800

0
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has announced the enrolment of the first patient in its observational COV-LOGIC (TNX-C001) study of cellular (T-cell) and humoral...

AIM ImmunoTech (NYSE:AMERICAN:AIM) Files Interim Patent Application For Using Ampligen To Treat SARS-CoV-2 Induced...

0
AIM ImmunoTech (NYSE:AMERICAN:AIM) has announced the filing of provisional patent application to use Ampligen as a possible early-onset therapy for COVID-19 induced CFS. The...

MAKE IT MODERN

POPULAR

[/tdc_zone]

.td-post-views{ display: none !important; }